Exhibit 99.1
Explanation of Responses
(1) Represents shares of common stock issuable upon conversion of 2,500,000
shares of Series A Convertible Preferred Stock convertible beginning on July 31,
  2008 for the number of shares obtained by dividing the aggregate liquidation
preference of such shares ($100 per share) by the then-effective conversion
price. The number of shares of common stock issuable upon conversion of such
shares of Series A Convertible Preferred Stock will depend upon the conversion
price which will be the product of 0.83 multiplied by the volume weighted
average sale price on the New York Stock Exchange or other principal securities
exchange upon which the issuer's common stock is then listed for the 22 trading
days beginning on and including February 1, 2008 (disregarding the trading days
during such period having the highest and lowest volume weighted average sale
price), subject to certain adjustments contained in the issuer's Certificate of
Designation of 4.0% Series A Convertible Preferred Stock and 4.0% Series B
Convertible Preferred Stock.
(2) As of February 8, 2008, of the 2,500,000 shares of Series A Convertible
Preferred Stock discussed in Note 1 above, 2,360,631 are held by Centerbridge
Capital Partners, L.P, 83,810 are held by Centerbridge Capital Partners
Strategic, L.P. and 50,559 are held by Centerbridge Capital Partners SBS, L.P.
and 5,000 are held by Centerbridge Capital Partners B Co-Investment, L.P.
Centerbridge Associates, L.P. is the general partner of Centerbridge Capital
Partners, L.P., Centerbridge Capital Partners Strategic, L.P., Centerbridge
Capital Partners SBS, L.P. and Centerbridge Capital Partners B Co-Investment,
L.P. Centerbridge GP Investors, LLC is the general partner of Centerbridge
Associates, L.P. Mr. Gallogly is a managing member of Centerbridge GP Investors,
  LLC and may be deemed to have beneficial ownership over such shares.
Nevertheless, Mr. Gallogly disclaims beneficial ownership of all such shares,
except to the extent of his pecuniary interest therein.

(3)  No Expiration Date.






- 2 -